First Time Loading...
R

Rekah Pharmaceutical Industry Ltd
TASE:REKA

Watchlist Manager
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Watchlist
Price: 1 300 ILS 3.92%
Updated: May 20, 2024

Rekah Pharmaceutical Industry Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rekah Pharmaceutical Industry Ltd
Cash from Financing Activities Peer Comparison

Comparables:
TEVA
TARO
I
INCR
MDWD
C
CSURE

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Cash from Financing Activities
-₪7.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-20%
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Cash from Financing Activities
-$1.4B
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
5%
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Cash from Financing Activities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InterCure Ltd
TASE:INCR
Cash from Financing Activities
-₪82.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Cash from Financing Activities
$22.9m
CAGR 3-Years
N/A
CAGR 5-Years
241%
CAGR 10-Years
2%
C
Cannassure Therapeutics Ltd
TASE:CSURE
Cash from Financing Activities
₪6.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Rekah Pharmaceutical Industry Ltd's Cash from Financing Activities?
Cash from Financing Activities
-7.8m ILS

Based on the financial report for Dec 31, 2023, Rekah Pharmaceutical Industry Ltd's Cash from Financing Activities amounts to -7.8m ILS.

What is Rekah Pharmaceutical Industry Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-20%

Over the last year, the Cash from Financing Activities growth was 68%.